IBDEI12X ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,19048,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19048,1,4,0)
 ;;=4^731.0
 ;;^UTILITY(U,$J,358.3,19048,1,5,0)
 ;;=5^Paget's Disease
 ;;^UTILITY(U,$J,358.3,19048,2)
 ;;=Paget's Disease^86892
 ;;^UTILITY(U,$J,358.3,19049,0)
 ;;=733.01^^105^1226^44
 ;;^UTILITY(U,$J,358.3,19049,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19049,1,4,0)
 ;;=4^733.01
 ;;^UTILITY(U,$J,358.3,19049,1,5,0)
 ;;=5^Osteoporosis, Senile
 ;;^UTILITY(U,$J,358.3,19049,2)
 ;;=Osteoporosis, Senile^87188
 ;;^UTILITY(U,$J,358.3,19050,0)
 ;;=733.02^^105^1226^43
 ;;^UTILITY(U,$J,358.3,19050,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19050,1,4,0)
 ;;=4^733.02
 ;;^UTILITY(U,$J,358.3,19050,1,5,0)
 ;;=5^Osteoporosis, Idiopathic
 ;;^UTILITY(U,$J,358.3,19050,2)
 ;;=Osteoporosis, Idiopathic^272692
 ;;^UTILITY(U,$J,358.3,19051,0)
 ;;=733.90^^105^1226^41
 ;;^UTILITY(U,$J,358.3,19051,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19051,1,4,0)
 ;;=4^733.90
 ;;^UTILITY(U,$J,358.3,19051,1,5,0)
 ;;=5^Osteopenia
 ;;^UTILITY(U,$J,358.3,19051,2)
 ;;=Osteopenia^35593
 ;;^UTILITY(U,$J,358.3,19052,0)
 ;;=733.13^^105^1226^9
 ;;^UTILITY(U,$J,358.3,19052,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19052,1,4,0)
 ;;=4^733.13
 ;;^UTILITY(U,$J,358.3,19052,1,5,0)
 ;;=5^Compression Fx of Spine
 ;;^UTILITY(U,$J,358.3,19052,2)
 ;;=Compression Fx of Spine^295754
 ;;^UTILITY(U,$J,358.3,19053,0)
 ;;=274.00^^105^1226^30
 ;;^UTILITY(U,$J,358.3,19053,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19053,1,4,0)
 ;;=4^274.00
 ;;^UTILITY(U,$J,358.3,19053,1,5,0)
 ;;=5^Gouty Arthritis NOS
 ;;^UTILITY(U,$J,358.3,19053,2)
 ;;=^338313
 ;;^UTILITY(U,$J,358.3,19054,0)
 ;;=274.01^^105^1226^33
 ;;^UTILITY(U,$J,358.3,19054,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19054,1,4,0)
 ;;=4^274.01
 ;;^UTILITY(U,$J,358.3,19054,1,5,0)
 ;;=5^Gouty Arthropathy, Acute
 ;;^UTILITY(U,$J,358.3,19054,2)
 ;;=^338226
 ;;^UTILITY(U,$J,358.3,19055,0)
 ;;=274.02^^105^1226^31
 ;;^UTILITY(U,$J,358.3,19055,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19055,1,4,0)
 ;;=4^274.02
 ;;^UTILITY(U,$J,358.3,19055,1,5,0)
 ;;=5^Gouty Arthritis, Chr
 ;;^UTILITY(U,$J,358.3,19055,2)
 ;;=^338227
 ;;^UTILITY(U,$J,358.3,19056,0)
 ;;=274.03^^105^1226^32
 ;;^UTILITY(U,$J,358.3,19056,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19056,1,4,0)
 ;;=4^274.03
 ;;^UTILITY(U,$J,358.3,19056,1,5,0)
 ;;=5^Gouty Arthritis, Chr w/ Tophi
 ;;^UTILITY(U,$J,358.3,19056,2)
 ;;=^338228
 ;;^UTILITY(U,$J,358.3,19057,0)
 ;;=729.90^^105^1226^65
 ;;^UTILITY(U,$J,358.3,19057,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19057,1,4,0)
 ;;=4^729.90
 ;;^UTILITY(U,$J,358.3,19057,1,5,0)
 ;;=5^Soft Tissue Disorder
 ;;^UTILITY(U,$J,358.3,19057,2)
 ;;=^336762
 ;;^UTILITY(U,$J,358.3,19058,0)
 ;;=729.91^^105^1226^57
 ;;^UTILITY(U,$J,358.3,19058,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19058,1,4,0)
 ;;=4^729.91
 ;;^UTILITY(U,$J,358.3,19058,1,5,0)
 ;;=5^Post-Traumatic Seroma
 ;;^UTILITY(U,$J,358.3,19058,2)
 ;;=^336654
 ;;^UTILITY(U,$J,358.3,19059,0)
 ;;=729.92^^105^1226^38
 ;;^UTILITY(U,$J,358.3,19059,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19059,1,4,0)
 ;;=4^729.92
 ;;^UTILITY(U,$J,358.3,19059,1,5,0)
 ;;=5^Non-Traumatic Hematoma Soft Tissue
 ;;^UTILITY(U,$J,358.3,19059,2)
 ;;=^336655
 ;;^UTILITY(U,$J,358.3,19060,0)
 ;;=729.99^^105^1226^66
 ;;^UTILITY(U,$J,358.3,19060,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19060,1,4,0)
 ;;=4^729.99
 ;;^UTILITY(U,$J,358.3,19060,1,5,0)
 ;;=5^Soft Tissue Disorder NEC
 ;;^UTILITY(U,$J,358.3,19060,2)
 ;;=^336656
 ;;^UTILITY(U,$J,358.3,19061,0)
 ;;=781.0^^105^1227^108
 ;;^UTILITY(U,$J,358.3,19061,1,0)
 ;;=^358.31IA^5^2
 ;;
 ;;$END ROU IBDEI12X
